Resmed launches HSAT across US
By HME News Staff
Updated 8:57 AM CDT, Mon April 7, 2025
SAN DIEGO – Resmed has announced that its home sleep apnea test, NightOwl, is now available across the U.S.
The test, which is cleared by the U.S. Food and Drug Administration, is designed to offer health care providers a simplified, accurate and efficient way to diagnose obstructive sleep apnea from the comfort of an individual’s home, the company says.
“Now more than ever, people want health care experiences that are easy, convenient, and accessible; however, navigating sleep apnea testing can be complex,” said Carlos M. Nunez, M.D., chief medical officer at Resmed. “With NightOwl, people can easily complete a sleep apnea test from the comfort of home using just a fingertip sensor and a smartphone. It also simplifies the process for providers. This is a meaningful step forward in Resmed’s mission to deliver life-changing health technology that people love.”
Resmed says NightOwl is a disposable HSAT device that:
- Records up to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a comprehensive view of an individual’s sleep patterns.
- Sends sleep data remotely to a cloud-based diagnostic platform for physician analysis and review, enabling quick interpretation, streamlining diagnostic workflows and helping individuals receive more timely diagnoses, if applicable.
Comments